Indian High Court in Chennai Delivers a Decisive Product Patent Victory to Kibow Biotech Inc Specializing in Kidney Health Supplement “Renadyl™” – the Flagship Product for its “Enteric Dialysis®” Platform Technology

Kibow Biotech Inc is pleased to announce that it has achieved a significant victory with its India patent in a lawsuit brought by La Renon an Ahmedabad based company. [Patent No. 351/MUMNP/2006, 224100 “Compositions for Augmenting Kidney Function” Patent No. 224100, – issued September 29, 2008]. La Renon had challenged the validity of Kibow’s patent […]

Kibow® Biotech to Participate in The Pediatric Academic Societies (PAS) 2018 Meeting, May 5-8, 2018 in Toronto, Canada

Kibow Biotech is pleased to be exhibiting for the first time at The Pediatric Academic Societies (PAS) Meeting, May 5-8, 2018 in Toronto, Canada, (https://www.pas-meeting.org/) where it will introduce its plan to develop clinical studies for pediatric CKD patients using its innovative dietary supplement product, Renadyl™, the first and only kidney health supplement formulated and […]

Kibow Fortis® Recently Featured at the 2018 Integrative Healthcare Symposium in New York, NY.

Kibow® Biotech, the 20-year-old Research & Development Company and creator of the World’s first probiotic kidney health supplement Renadyl™, are announcing the availability of Kibow Fortis® a premium multi-fiber prebiotic supplement. Kibow Fortis, the world’s most comprehensive multi-fiber supplement is comprised of 6 prebiotic fibers. Other fiber supplements primarily use only psyllium husk and methylcellulose; […]

We use cookies

We use cookies to improve your experience on this website. You may choose which types of cookies to allow and change your preferences at any time. Disabling cookies may impact your experience on this website. You can learn more by viewing our Cookie Policy.